GAIN THERAPEUTICS, INC Deferred Income
GAIN THERAPEUTICS, INC (GANX) had Deferred Income of $11.29 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredIncome · last filed 2026-03-26
- 2025-09-30: Deferred Income $11.29K.
- 2025-06-30: Deferred Income $22.68K.
- 2025-03-31: Deferred Income $217.84K.
- 2024-12-31: Deferred Income $299.65K.
| Period end | Deferred Income |
|---|---|
| 2025-09-30 | $11.29K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $22.68K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $217.84K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $299.65K 10-K · filed 2026-03-26 |
| 2024-09-30 | $773.90K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $790.37K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $979.06K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.22M 10-K · filed 2025-03-27 |
| 2023-09-30 | $1.35M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.68M 10-Q · filed 2023-08-10 |
| 2022-12-31 | $55.18K 10-K · filed 2024-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |